APA (7th ed.) Citation

Roche, M., Salimi, H., Duncan, R., Wilkinson, B. L., Chikere, K., Moore, M. S., . . . Gorry, P. R. (2013). A common mechanism of clinical HIV-1 resistance to the CCR5 antagonist maraviroc despite divergent resistance levels and lack of common gp120 resistance mutations. Retrovirology, 10(1), 43. https://doi.org/10.1186/1742-4690-10-43

Chicago Style (17th ed.) Citation

Roche, Michael, et al. "A Common Mechanism of Clinical HIV-1 Resistance to the CCR5 Antagonist Maraviroc Despite Divergent Resistance Levels and Lack of Common Gp120 Resistance Mutations." Retrovirology 10, no. 1 (2013): 43. https://doi.org/10.1186/1742-4690-10-43.

MLA (9th ed.) Citation

Roche, Michael, et al. "A Common Mechanism of Clinical HIV-1 Resistance to the CCR5 Antagonist Maraviroc Despite Divergent Resistance Levels and Lack of Common Gp120 Resistance Mutations." Retrovirology, vol. 10, no. 1, 2013, p. 43, https://doi.org/10.1186/1742-4690-10-43.